2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with Leukopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R | 1 |
Biftu, T; Doebber, TW; Wu, MS | 1 |
2 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and Leukopenia
Article | Year |
---|---|
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
Topics: Acetylglucosaminidase; Animals; Blood Pressure; Endotoxins; Female; Furans; Hydrolases; Leukopenia; Lysosomes; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1986 |